Medtech Is Getting Tinier: Here Are 5 Recent Advances

March 26, 2015

6 Slides
Medtech Is Getting Tinier: Here Are 5 Recent Advances
Medtech Is Getting Tinier: Here Are 5 Recent AdvancesGoogle made waves last year when it announced an ambitious project to develop disease-detecting nanoparticles. But it really is only the tip of the iceberg when it comes to the way that medtech is turning to tiny solutions to combat the Goliaths of the disease world such as cancer and heart disease.In cardiology, innovators are working on everything from nanosensors that could detect heart attacks before they happen, to pill-sized leadless pacemakers. Meanwhile, electronics are being crammed into device components that formerly never had them.While miniaturization is not new to medtech, the trend it seems, is only accelerating, with Qmed noticing an uptick in stories in recent months about research breakthroughs related to tiny technologies. Read on to find out about five that especially caught our eye.Refresh your medical device industry knowledge at BIOMEDevice Boston, May 6–7, 2015.Chris Newmarker is senior editor of Qmed and MPMN. Follow him on Twitter at @newmarker.Like what you’re reading? Subscribe to our daily e-newsletter.

Medtech Is Getting Tinier: Here Are 5 Recent Advances

Google made waves last year when it announced an ambitious project to develop disease-detecting nanoparticles. But it really is only the tip of the iceberg when it comes to the way that medtech is turning to tiny solutions to combat the Goliaths of the disease world such as cancer and heart disease.

In cardiology, innovators are working on everything from nanosensors that could detect heart attacks before they happen, to pill-sized leadless pacemakers. Meanwhile, electronics are being crammed into device components that formerly never had them.

While miniaturization is not new to medtech, the trend it seems, is only accelerating, with Qmed noticing an uptick in stories in recent months about research breakthroughs related to tiny technologies. Read on to find out about five that especially caught our eye.

Chris Newmarker is senior editor of Qmed and MPMN. Follow him on Twitter at @newmarker.

Like what you’re reading? Subscribe to our daily e-newsletter.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like